The Cigna Group (NYSE:CI) Shares Bought by Goldstein Advisors LLC

Goldstein Advisors LLC lifted its holdings in shares of The Cigna Group (NYSE:CI) by 6.5% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 833 shares of the health services provider’s stock after purchasing an additional 51 shares during the quarter. Goldstein Advisors LLC’s holdings in The Cigna Group were worth $275,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Hanson & Doremus Investment Management raised its holdings in shares of The Cigna Group by 3.5% in the 1st quarter. Hanson & Doremus Investment Management now owns 867 shares of the health services provider’s stock worth $315,000 after purchasing an additional 29 shares during the period. Capital Asset Advisory Services LLC raised its holdings in The Cigna Group by 2.3% in the first quarter. Capital Asset Advisory Services LLC now owns 1,280 shares of the health services provider’s stock valued at $464,000 after buying an additional 29 shares during the period. Capital Advisors Ltd. LLC lifted its position in The Cigna Group by 10.6% during the first quarter. Capital Advisors Ltd. LLC now owns 335 shares of the health services provider’s stock valued at $122,000 after buying an additional 32 shares in the last quarter. Capital Investment Advisors LLC grew its stake in The Cigna Group by 2.9% during the second quarter. Capital Investment Advisors LLC now owns 1,122 shares of the health services provider’s stock worth $371,000 after buying an additional 32 shares during the period. Finally, First Financial Corp IN increased its position in shares of The Cigna Group by 17.2% in the first quarter. First Financial Corp IN now owns 225 shares of the health services provider’s stock worth $82,000 after acquiring an additional 33 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling at The Cigna Group

In other The Cigna Group news, insider Brian C. Evanko sold 4,795 shares of the stock in a transaction that occurred on Monday, June 24th. The shares were sold at an average price of $345.01, for a total value of $1,654,322.95. Following the completion of the sale, the insider now owns 39,923 shares in the company, valued at approximately $13,773,834.23. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, insider Brian C. Evanko sold 4,795 shares of the stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of $345.01, for a total value of $1,654,322.95. Following the transaction, the insider now owns 39,923 shares in the company, valued at $13,773,834.23. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Elder Granger sold 547 shares of The Cigna Group stock in a transaction that occurred on Monday, June 17th. The shares were sold at an average price of $331.38, for a total transaction of $181,264.86. Following the completion of the sale, the director now owns 5,471 shares of the company’s stock, valued at $1,812,979.98. The disclosure for this sale can be found here. Insiders have sold a total of 9,033 shares of company stock valued at $3,095,820 in the last 90 days. 0.60% of the stock is currently owned by corporate insiders.

The Cigna Group Price Performance

Shares of NYSE:CI traded up $7.10 during trading hours on Friday, hitting $353.57. 999,284 shares of the company’s stock traded hands, compared to its average volume of 1,541,428. The company’s fifty day simple moving average is $335.68 and its two-hundred day simple moving average is $341.76. The company has a market cap of $100.44 billion, a price-to-earnings ratio of 28.45, a price-to-earnings-growth ratio of 1.02 and a beta of 0.52. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.71 and a current ratio of 0.71. The Cigna Group has a 52 week low of $253.95 and a 52 week high of $365.71.

The Cigna Group (NYSE:CI) last announced its earnings results on Thursday, August 1st. The health services provider reported $6.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.42 by $0.30. The company had revenue of $60.52 billion for the quarter, compared to analyst estimates of $58.30 billion. The Cigna Group had a return on equity of 17.83% and a net margin of 1.70%. The Cigna Group’s revenue for the quarter was up 24.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $6.13 earnings per share. As a group, equities analysts anticipate that The Cigna Group will post 28.4 EPS for the current fiscal year.

The Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 19th. Shareholders of record on Wednesday, September 4th will be given a dividend of $1.40 per share. The ex-dividend date is Wednesday, September 4th. This represents a $5.60 dividend on an annualized basis and a yield of 1.58%. The Cigna Group’s payout ratio is presently 45.98%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. StockNews.com raised shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 2nd. Oppenheimer boosted their price target on The Cigna Group from $370.00 to $400.00 and gave the stock an “outperform” rating in a research note on Friday, May 3rd. JPMorgan Chase & Co. lifted their price objective on The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a report on Wednesday. Baird R W upgraded The Cigna Group to a “strong-buy” rating in a research note on Thursday, May 30th. Finally, Stephens restated an “overweight” rating and issued a $410.00 price target on shares of The Cigna Group in a research note on Friday, August 2nd. One equities research analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $384.86.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.